Plain language summary of the design of the TALAPRO-2 study comparing talazoparib and enzalutamide versus enzalutamide and placebo in men with metastatic castration-resistant prostate cancer Article

cited authors

  • Agarwal, Neeraj; Azad, Arun; Shore, Neal D.; Carles, Joan; Fay, Andre P.; Dunshee, Curtis; Karsh, Lawrence Ivan; Paccagnella, Maria Luisa; Di Santo, Nicola; Elmeliegy, Mohamed; Lin, Xun; Czibere, Akos; Fizazi, Karim

authors

Publication Date

  • August 11, 2022

webpage

published in

category

keywords

  • clinical trial
  • enzalutamide
  • lay summary
  • metastatic castration-resistant prostate cancer
  • plain language summary
  • talazoparib

start page

  • 2979

end page

  • 2986

volume

  • 18

issue

  • 27